Cargando…
WDR26 and MTF2 are therapeutic targets in multiple myeloma
Unbiased genetic forward screening using retroviral insertional mutagenesis in a genetically engineered mouse model of human multiple myeloma may further our understanding of the genetic pathways that govern neoplastic plasma cell development. To evaluate this hypothesis, we performed a tumor induct...
Autores principales: | Sun, Fumou, Cheng, Yan, Riordan, Jesse D., Dupuy, Adam, Dubois, Wendy, Pisano, Michael, Dong, Jing, Mock, Beverly, Zhan, Fenghuang, Hari, Parameswaran, Janz, Siegfried |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650373/ https://www.ncbi.nlm.nih.gov/pubmed/34876184 http://dx.doi.org/10.1186/s13045-021-01217-9 |
Ejemplares similares
-
Germline Risk Contribution to Genomic Instability in Multiple Myeloma
por: Janz, Siegfried, et al.
Publicado: (2019) -
Laboratory Mice – A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma
por: Pisano, Michael, et al.
Publicado: (2021) -
FOXM1 regulates glycolysis and energy production in multiple myeloma
por: Cheng, Yan, et al.
Publicado: (2022) -
Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?
por: Franqui-Machin, Reinaldo, et al.
Publicado: (2015) -
The CMS Modular Track Finder Boards, MTF6 and MTF7
por: Acosta, Darin Edward, et al.
Publicado: (2013)